The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| CYTOKINETICS INC | COM NEW | 23282W605 | 18,958 | 875,656 | SH | DFND | 1 | 875,656 | 0 | 0 | |
| IMMUNOMEDICS INC | COM | 452907108 | 371,851 | 4,373,178 | SH | DFND | 1 | 4,373,178 | 0 | 0 | |
| BIOHAVEN PHARMACTL HLDG CO L | COM | G11196105 | 137,243 | 2,111,111 | SH | DFND | 1 | 2,111,111 | 0 | 0 | |
| SUNESIS PHARMACEUTICALS INC | COM NEW | 867328700 | 16 | 129,517 | SH | DFND | 1 | 129,517 | 0 | 0 | |
| EPIZYME INC | COM | 29428V104 | 109,358 | 9,166,667 | SH | DFND | 1 | 9,166,667 | 0 | 0 | |
| EPIZYME INC | COM | 29428V904 | 29,825 | 2,500,000 | SH | Call | DFND | 1 | 2,500,000 | 0 | 0 |